Search
Search Constraints
You searched for: Author/Creator Leeb, B- Leeb, B [remove] 7
- 616.723005 7
- Rheumatism -- Periodicals 7
- ACR, American College of Rheumatology -- DAS28, 28 joint disease activity score -- DMARD, disease modifying antirheumatic drug -- EULAR, European League Against Rheumatism -- fMRP, functional multidrug resistance proteins -- FPGS, folylpolyglutamyl synthetase -- MRP, multidrug resistance protein family -- NSAID, non-steroidal anti-inflammatory drug -- RFC, reduced folate carrier -- VAS, visual analogue scale 1
- AHS, allopurinol hypersensitivity syndrome -- ES, effect size -- ESCISIT, EULAR Standing Committee for International Clinical Studies Including Therapeutics -- EULAR, European League Against Rheumatism -- ICER, incremental cost-effectiveness ratio -- NNT, number needed to treat -- NSAID, non-steroidal anti-inflammatory drug -- QALY, quality of life years -- RCT, randomised controlled trial -- SOR, strength of recommendation -- SUA, serum uric acid -- VAS, visual analogue scale 1
- ASU, avocado soybean unsaponifiable -- CI, confidence interval -- COX-2, cyclo-oxygenase-2 -- CS, chondroitin sulphate -- CT, controlled trial -- CV, cardiovascular -- ES, effect size -- GI, gastrointestinal -- GS, glucosamine sulphate -- HA, hyaluronic acid -- ICER, incremental cost effectiveness ratio -- NNT, number needed to treat -- NSAIDs, non-steroidal anti-inflammatory drugs -- QALY, quality of life year -- OA, osteoarthritis -- OR, odds ratio -- PPI, proton pump inhibitor -- RCT, randomised controlled trial -- RR, relative risk -- SYSADOA, symptomatic slow acting drugs for OA -- THR, total hip replacement -- VAS, visual analogue scale 1
- ES, effect size -- HA, hyaluronic acid -- NSAIDs, non-steroidal anti-inflammatory drugs -- OA, osteoarthritis -- QS, quality score -- RCT, randomised controlled trial -- TKR, total knee replacement 1
- ESCISIT -- EULAR -- hips -- osteoarthritis -- recommendation 1
- ESCISIT, EULAR Standing Committee for International Clinical Studies Including Therapeutics -- EULAR, European League Against Rheumatism -- ICER, incremental cost-effectiveness ratio -- LR, likelihood ratio -- MSU, monosodium urate -- SOR, strength of recommendation -- SUA, serum uric acid -- VAS, visual analogue scale 1
- EULAR -- gout -- guidelines -- treatment 1
- EULAR -- guidelines -- gout -- diagnosis 1